Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Retifanlimab |
Trade Name | |
Synonyms | MGA 012|INCMGA00012|MGA012 |
Drug Descriptions |
Retifanlimab (INCMGA00012) is a humanized IgG4 monoclonal antibody that targets PD-1 (PDCD1) and inhibits binding of the PD-L1 (CD274) ligand, potentially resulting in enhanced anti-tumor immune response (AACR; Cancer Res 2019;79(13 Suppl):Abstract nr CT085). |
DrugClasses | Immune Checkpoint Inhibitor 151 PD-L1/PD-1 antibody 98 |
CAS Registry Number | 2226345-85-1 |
NCIT ID | C142168 |